Detection of Minimal Residual Disease in Hematopoietic Tissues a

[1]  R. Sackstein.  Lymphocyte Migration Following Bone Marrow Transplantation , 1995, Annals of the New York Academy of Sciences.

[2]  N. Gorin.  Stem Cell Transplantation in Acute Leukemia , 1995, Annals of the New York Academy of Sciences.

[3]  J. Sharp,et al.  Culture methods for the detection of minimal tumor contamination of hematopoietic harvests: a review. , 1995, Journal of hematotherapy.

[4]  J. Jackson,et al.  Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. , 1995, Blood.

[5]  L. Fouillard,et al.  Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. , 1995, Blood.

[6]  D. Campana,et al.  Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. , 1995, Blood.

[7]  A Benner,et al.  p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. , 1995, Blood.

[8]  F. Coutlée,et al.  A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma. , 1994, Molecular and cellular probes.

[9]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[10]  J. Neglia,et al.  Autologous Peripheral Blood Cell Transplantation in the Treatment of Advanced Neuroblastoma , 1994, The American journal of pediatric hematology/oncology.

[11]  Osborne Mp,et al.  Detection and management of bone marrow micrometastases in breast cancer. , 1994 .

[12]  Sutherland,et al.  Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. , 1994, Blood.

[13]  J. Ihle,et al.  Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells , 1994 .

[14]  X. Mariette,et al.  Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. , 1994, Bone marrow transplantation.

[15]  J. Gribben,et al.  Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow , 1994 .

[16]  S. Shousha,et al.  Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. , 1994, Cancer research.

[17]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[18]  N. Boiani,et al.  Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines , 1994 .

[19]  H. Döhner,et al.  Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. , 1994, Blood.

[20]  K W Kohn,et al.  Cell cycle control and cancer chemotherapy , 1994, Journal of cellular biochemistry.

[21]  R. Schwartz,et al.  Immunoglobulin V regions and the B cell. , 1994, Blood.

[22]  S. Ethier,et al.  Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  L. Kanz,et al.  Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments] , 1994 .

[24]  E. Shpall,et al.  Release of tumor cells from bone marrow. , 1994, Blood.

[25]  D. Porter,et al.  Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. , 1994, The New England journal of medicine.

[26]  M. Greaves,et al.  Use of granulocyte colony‐stimulating factor (G‐CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration , 1994, British journal of haematology.

[27]  N. Russell,et al.  Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. , 1993, Bone marrow transplantation.

[28]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[29]  K. Akashi,et al.  Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction , 1993, British journal of haematology.

[30]  K. Kohn,et al.  Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. , 1993, Cancer research.

[31]  D. Longo,et al.  p53 mutation is associated with progression in follicular lymphomas. , 1993, Blood.

[32]  T. Lister,et al.  Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. , 1993, Blood.

[33]  M. Andreeff,et al.  Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. , 1993, The New England journal of medicine.

[34]  L. Kumar.  Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation. , 1993, Leukemia & lymphoma.

[35]  J. Izbicki,et al.  Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. , 1993, Cancer research.

[36]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[37]  G. Bastert,et al.  Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  G. Schlimok,et al.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients , 1992, The Lancet.

[39]  C. Higano,et al.  Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation. , 1992, Blood.

[40]  D. Weisenburger,et al.  Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. , 1992, Blood.

[41]  J. Gribben,et al.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.

[42]  J. Ritz,et al.  Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. , 1991, Blood.

[43]  K. Pantel,et al.  Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. , 1991, European journal of cancer.

[44]  B. Calabretta,et al.  Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. , 1991, Science.

[45]  G. Morgan,et al.  Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. , 1991, Blood.

[46]  J C Reed,et al.  Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. , 1990, Cancer research.

[47]  C. Bartram,et al.  Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. , 1989, Blood.

[48]  J. Chang,et al.  Long-term bone marrow cultures: their use in autologous marrow transplantation. , 1989, Cancer cells.

[49]  B. Lange,et al.  Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Strobel,et al.  Effects of human bone marrow stroma on the growth of human tumor cells. , 1989, Cancer research.

[51]  F. Galibert,et al.  In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. , 1989, Leukemia.

[52]  D. Zipori,et al.  Stromal cell effects on clonal growth of tumors , 1987, Cancer.

[53]  D. Weisenburger,et al.  Detection of malignant cells in histologically normal bone marrow using culture techniques. , 1987, Bone marrow transplantation.

[54]  R. Dalla‐Favera,et al.  Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Trueworthy,et al.  Utilization of a human tumor cloning system to monitor for bone marrow involvement in children with non‐Hodgkin's lymphoma , 1984, Cancer.

[56]  I. Magrath,et al.  Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement. , 1983, Blood.

[57]  D. Weisenburger,et al.  Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  W. Chan,et al.  Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents. , 1995, Leukemia & lymphoma.

[59]  T. Greiner,et al.  Detection of tumor contamination of peripheral stem cells in patients with lymphoma using cell culture and polymerase chain reaction technology. , 1994, Journal of hematotherapy.

[60]  R. Collins.  CD34+ selected cells in clinical transplantation , 1994, Stem cells.

[61]  A. Biondi,et al.  Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia , 1994, Stem cells.

[62]  A. Gewirtz.  Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia. , 1993, Leukemia & lymphoma.

[63]  J. Goldman,et al.  Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction. , 1993, Leukemia & lymphoma.

[64]  D. Weisenburger,et al.  Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests , 1992 .

[65]  M. Labopin,et al.  Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe : further evidence of the role of marrow purging by mafosfamide , 1991 .

[66]  E. Thiel,et al.  Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses. , 1991, Leukemia & lymphoma.

[67]  J. Goldman,et al.  Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help? , 1990, Bone marrow transplantation.

[68]  D. Weisenburger,et al.  Levels of detection of tumor cells in human bone marrow with or without prior culture. , 1990, Bone Marrow Transplantation.

[69]  A. Ford,et al.  Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC) , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.